Jump to content

Search the Community

Showing results for tags 'cancer'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Comment Card
    • Announcements
  • The Cafe
    • City Guide
    • IHOG: International House of Grads
    • The Lobby
  • Applying to Graduate School
    • The April 15th is this week! Freak-out forum.
    • Applications
    • Questions and Answers
    • Waiting it Out
    • Decisions, Decisions
    • The Bank
  • Grad School Life
    • Meet and Greet
    • Officially Grads
    • Coursework, Advising, and Exams
    • Research
    • Teaching
    • Writing, Presenting and Publishing
    • Jobs
  • The Menu
    • Applied Sciences & Mathematics
    • Arts
    • Humanities
    • Interdisciplinary Studies
    • Life Sciences
    • Physical Sciences
    • Professional Programs
    • Social Sciences

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


AIM


MSN


Website URL


ICQ


Yahoo


Jabber


Skype


Pronouns


Location


Interests


Program

Found 7 results

  1. Innovation Info Conferences proudly announces the International Conference on Pharmaceutical Sciences and Drug Development (IPSDD 2018) to be held during November 05-06, 2018 in Prague, Czech Republic. The IPSDD 2018 Conference is organized by the Innovation Info Conferences (IIC). The theme of the conference is "Embracing Innovative Technologies in Drug Development, Manufacturing and Discovery", will underpin the need for collaboration and cooperation of individuals from a wide range of professional, academic and technological backgrounds. IPSDD 2018 aims to bring together a wide range of active expertise, covering all stages of developments from lab to consumer: scientists, researchers (senior and young), academicians, clinical pharmacists, companies, investors and regulatory authorities. Moreover, the meeting is designed to serve as an effective international platform for all participants for networking as well as to contribute to the discussions on innovative technologies employed in modern drug discovery and delivery to promote development of efficacious novel drugs. Interested people can register and submit abstract here: Website: http://www.pharmascienceconferences.com Topics: Drug discovery, pharmaceutical ingredients, Pharma Conferences, Drug affinity, Genomics, proteomics and Bioinformatics, pharmaceutical Nanotechnology, , drug resistance, brain drug delivery, Nanomaterials, Polymer Chemistry, drug development, Drug Designing, Drug screening, Drug Carriers, Regulatory Intelligence, Pharmaceutical Market, Pharmacotherapy, Pharmacotherapy, Medicinal Chemistry, Pharmaceutical Nano systems, Pharmaceutical Nano systems, IPSDD, Pharmaceutical Nano systems, Pharmacist, Clinical Pharmacy, Patient compliance, Pharmacology and Toxicology.
  2. Hi everyone! I am so excited to start grad school next fall but am faced with a really tough decision!! I am really interested in cancer biology, and would study a wide range of topics within the field. I am deciding between gerstner Sloan Kettering and MIT! Both schools have lots of faculty I am interested in so its difficult to decide, and as you can see I can't seem to think of many cons to either- so I could really use some advice! Here are some pros and cons I came up with: GSK: More translational research, biomedical focus, Manhattan, awesome housing, clinical program, also has cancer immunology MIT: Its MIT, in the center of biotech, broader training, Boston, collaborative across many disciplines, I am interested potentially in doing a some what computationally related project and they have many cancer biologists who do this, an especially intense/intellectually stimulating environment Cons GSK: very cancer bio focused, newer program MIT: Lack of cancer immunology, kind of want to leave boston Thanks so much in advance!
  3. I am an international applicant. As I have applied for fall, 2017 for MD Anderson, I still haven't heard from them. Does anybody here applied to MD Anderson knows when we should expect an answer?? Thanks.
  4. I'm applying to Johns Hopkins, Northwestern University, Mt Sinai, Baylor College of Medicine and UC Davis. I currently have a horrible GRE score. I did not have a chance to study for it (collectively a week), but I had to apply this cycle given the fact that I'm in a research program that requires that I apply. I wanted to apply for MSTP programs next year, but my program advisor told me that I had to apply this year in order to receive funding until July of next year, so I took the GRE just in time for them to be received at the schools I'm applying to: V 150 Q 144 A 3.0 Do I have a chance? Any advice or support is appreciated. Thanks EDUCATION 08/2006 - 05/2008 Tuskegee University (Tuskegee, Alabama ) GPA: 3.89 Major: Biology and Nutritional Science 08/2008 - 12/2012 Auburn University (Auburn, Alabama) BS in Biomedical Sciences, BA in Spanish GPA: 3.43 Honors Thesis (2012): Immobilized transition metal complexes as macromolecular catalysts. ACHIEVEMENTS 2013 - 2014 U.S. Fulbright Scholar Program, Chemistry (Barcelona, Spain) 2015 - Present Hopkins PREP Scholar, NIH-funded Post-baccalaureate Research Education Program, Johns Hopkins University School of Medicine. AWARDS 2008 Bill Ellard Memorial Endowed Scholarship, Auburn University 2008 Thomas G. Jones Scholarship, Auburn University 2010 American Chemical Society’s Regional Conference Travel Grant 2010 Dean’s Research Award for Undergraduates, Auburn University 2011-2012 COSAM Undergraduate Research Fellowship, Auburn University PUBLICATIONS 2010 Gichinga MG, Striegler S*, Dunaway NA and Barnett JD, Miniemulsion polymers as solid support for transition metal catalysts, Polymer 2010, 51, 606-615. Striegler S,* Dunaway NA, Gichinga MG, Barnett JD and Nelson AG, Evaluating binuclear copper(II) complexes for glycoside hydrolysis, Inorg. Chem. 2010, 49, 2639- 2648. 2012 Dunaway NA, Barnett JD and Striegler S*, Glycoside hydrolysis with sugar-templated microgel catalysts, ACS Catalysis 2012, 2, 50-55. Barnett JD, and Striegler S*, Tuning templated microgel catalysts for selective glycoside hydrolysis, Topics in Catalysis 2012, 55(7) , 460-465. 2014 Fan QH, Striegler S*, Langston RG and Barnett JD, Evaluating N-benzylgalactonoamidines as putative transition state analogs for β-galactoside hydrolysis, Org. Biomol. Chem. 2014, 12(17) 2792-2800 2016 Korangath P, Barnett JD, et al., Nanoparticles and their targeting: a study in preclinical models of HER+ breast cancer, (manuscript in preparation) RESEARCH EXPERIENCE: 05/2008 - 07/2008 Undergraduate Molecular Biology & Immunology Researcher (UNT Health Science Center) Research Topic: Abundant expression of novel gene C17orf37 in prostate cancer 2009 - 2012 Undergraduate Inorganic Chemistry Researcher (Auburn University) Topic: Analysis of transition metal complexes as macromolecular catalysts 02/2013 - 08/2013 Chemistry Research Associate (University of Arkansas: Fayetteville) Topic: Preparation and evaluation of polymer matrices for asymmetric catalysis 09/2013 - 08/2014 Fulbright Scholar (University of Barcelona) Topic: Synthesis and characterization of photoactivatable DNA-cleaving copper complexes 07/2015 - Present PREP Scholar (Johns Hopkins University School of Medicine) Topic: Effects of magnetic nanoparticle-mediated hyperthermia on DNA damage repair pathways in colorectal cancer cells POSTERS & PRESENTATIONS 7/24/2008 Barnett JD. Novel gene C17orf37 is abundantly expressed in prostate cancer: a prospective biomarker. Poster; Univ. North Texas Health Science Center (Fort Worth, TX) 02/19/2010 Dunaway NA, Barnett JD and Striegler S. Carbohydrate recognition by binuclear platinum complexes. Poster; Auburn University (Dept. Chemistry and Biochemistry) 12/3/2010 Barnett JD, Alonso NA, and Striegler S. Sugar discrimination by binuclear copper(II) complexes. Poster. 66th Southwest and 62nd Southeastern Regional Meeting of the American Chemical Society. (New Orleans, LA) 03/30/2012 Barnett JD and Striegler S. Transition metal complexes as macromolecular catalysts. Poster. 26th National Conference on Undergraduate Research (NCUR) (Ogden,UT) 10/22/2015 Barnett JD. Effects of nanoparticles and nanoparticle-Induced hyperthermia on DNA Signaling Pathways in human colorectal cancer cells. Poster. Dept. Molecular Radiation Sciences, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine (Baltimore MD). 04/13/2016 Barnett JD, Sharma A, Bunz F and Ivkov R. Effects of magnetic nanoparticle-induced hyperthermia on DNA damage signaling. Oral presentation. 2016 Int’l Congress of Hyperthermic Oncology (New Orleans, LA)
  5. Hey all, I'm trying to decide between enrolling in Tulane's Biomedical Sciences program and UMD - Baltimore's Molecular Medicine program for Fall 2016. I would like to focus on cancer genetics, but realize that people do switch their focus once beginning these programs. I liked the professors more at Tulane and was more interested in their research, but UMD is ranked higher. Do school rankings matter much in research? If anyone has any insight into either of these two programs, any advice would be welcome. Thanks
  6. Has anyone else struggled with medical issues in grad school? I was diagnosed with a "benign" tumor right and had to have radiation treatment. I'm super lucky that my amazing grad student insurance covered all of the bills and I got to go to the University's amazing medical school hospital for treatment. That said, I'm still struggling with some issues related to the tumor and am wondering how others deal with medical situations in grad school. Are there even others out there like me? Where do you get support from? Do you feel like you face a stigma from your department? How has your advisor reacted? ETA: If you don't want to come out with it on the board, maybe you would be willing to PM me? I know that some people are private about medical stuff and don't want to talk about it.
  7. Hi everyone! I am an international student and intend to pursue PhD in genetics (preferably cancer genetics). Can anyone suggest good schools in this field. My GRE score: verbal: 640, Quant: 690, AW: 4.0. My TOEFL ibt score is 116/120. I hold an MSc degree in Genetics which is equivalent to a BS degree in the US. I had graduated top of my class. Have teaching experience of 6+ years. Finished a one yr. research project, working on another one right now but the topic is different from my intended PhD research topic. No publications yet Applied for Fulbright, made it to the interview but will hear final word by October. Could somebody suggest good schools or programs matching my profile that I could apply to, preferably in NY, Michigan, Pennsylvania or Ohio.
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use and Privacy Policy.